Cardiff Oncology Inc (CRDF) is up Thursday morning, with the stock gaining 7.22% in pre-market trading to 5.79. CRDF's short-term technical score of 98 indicates that the stock has traded more bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 101 out of 146 industries, the stock ranks higher than 99% of stocks. Cardiff Oncology Inc has risen 196.70% over the past month, closing at $1.75 on February 15. During this period of time, the stock fell as low as $1.67 and as high as $4.59. CRDF has an average analyst recommendation of Strong Buy. The company has an average price target of $10.50.
CRDF has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on CRDF!